Skip to main content

Peer Review reports

From: Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

Original Submission
16 Nov 2006 Submitted Original manuscript
4 Dec 2006 Reviewed Reviewer Report - Shinichi Tsutsui
18 Jan 2007 Reviewed Reviewer Report - Peter Sinn
21 Mar 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 2
21 Mar 2007 Submitted Manuscript version 2
23 Mar 2007 Reviewed Reviewer Report - Shinichi Tsutsui
4 Apr 2007 Reviewed Reviewer Report - Peter Sinn
10 Apr 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 3
10 Apr 2007 Submitted Manuscript version 3
11 Apr 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 4
11 Apr 2007 Submitted Manuscript version 4
Publishing
12 Apr 2007 Editorially accepted
12 Apr 2007 Article published 10.1186/1471-2407-7-63

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us